Literature DB >> 22920819

Analysis of comparison of patient preference for two insulin injection pen devices in relation to patient dexterity skills.

Kellie J Antinori-Lent1.   

Abstract

Insulin therapy is the cornerstone of medical treatment for many patients with diabetes. Self-administration of this life-saving medication is no longer limited to the traditional vial and syringe. Instead, more and more patients worldwide are using prefilled insulin pen devices. Ease of use, convenience, confidence in dosing accuracy, and improved quality of life are just a few of their advantages. As with any medical technology, safe and proper use is vital. Many studies have examined pen device preference and usability. Until now, no study has included patients with both visual and dexterity impairments. To ensure safe and simple self-administration of insulin for all patients, it is time for the special needs of patients with diabetes to be considered not only during product development, but during postmarketing studies as well.
© 2012 Diabetes Technology Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22920819      PMCID: PMC3440164          DOI: 10.1177/193229681200600424

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  19 in total

1.  Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies.

Authors:  Richard R Rubin; Mark Peyrot
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

Review 2.  Insulin delivery using pen devices. Simple-to-use tools may help young and old alike.

Authors:  N J Bohannon
Journal:  Postgrad Med       Date:  1999-10-15       Impact factor: 3.840

3.  Patient and physician satisfaction with the Humulin/Humalog Pen, a new 3.0-mL prefilled pen device for insulin delivery.

Authors:  N J Bohannon; J P Ohannesian; A L Burdan; J H Holcombe; A Zagar
Journal:  Clin Ther       Date:  2000-09       Impact factor: 3.393

4.  Assessment of dose selection attributes with audible notification in insulin pen devices.

Authors:  Toshinari Asakura; Hiroaki Seino
Journal:  Diabetes Technol Ther       Date:  2005-08       Impact factor: 6.118

5.  Preference for insulin delivery systems among current insulin users and nonusers.

Authors:  Kent H Summers; Sheryl L Szeinbach; Sheila M Lenox
Journal:  Clin Ther       Date:  2004-09       Impact factor: 3.393

6.  A comparison of insulin pen use in the United States and the United Kingdom.

Authors:  Sara Da Costa; Betty Brackenridge; Debbie Hicks
Journal:  Diabetes Educ       Date:  2002 Jan-Feb       Impact factor: 2.140

7.  Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old.

Authors:  C Coscelli; S Lostia; M Lunetta; I Nosari; G A Coronel
Journal:  Diabetes Res Clin Pract       Date:  1995-06       Impact factor: 5.602

Review 8.  FlexPen: addressing issues of confidence and convenience in insulin delivery.

Authors:  Mary Korytkowski; Leo Niskanen; Toshinari Asakura
Journal:  Clin Ther       Date:  2005       Impact factor: 3.393

9.  A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.

Authors:  Mary Korytkowski; David Bell; Carol Jacobsen; Rudee Suwannasari
Journal:  Clin Ther       Date:  2003-11       Impact factor: 3.393

10.  Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe.

Authors:  M R Graff; M A McClanahan
Journal:  Clin Ther       Date:  1998 May-Jun       Impact factor: 3.393

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.